Ikarian Capital’s Celldex Therapeutics CLDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $14.6M | Buy |
|
|||||
|
2025
Q2 | – | Hold |
|
|||||
|
2025
Q1 | – | Hold |
|
|||||
|
2024
Q4 | – | Hold |
|
|||||
|
2024
Q3 | – | Hold |
|
|||||
|
2024
Q1 | – | Hold |
|
|||||
|
2023
Q4 | – | Hold |
|
|||||
|
2023
Q3 | – | Hold |
|
|||||
|
2023
Q2 | – | Sell |
|
|||||
|
2023
Q1 | $3.82M | Sell |
|
|||||
|
2022
Q4 | $11.9M | Sell |
|
|||||
|
2022
Q3 | $8.92M | Sell |
|
|||||
|
2022
Q2 | $14.5M | Hold |
|
|||||
|
2022
Q1 | $18.3M | Buy |
|
|||||
|
2021
Q4 | $16.2M | Buy |
|
|||||
|
2021
Q3 | $14.6M | Sell |
|
|||||
|
2021
Q2 | $12.2M | Sell |
|
|||||
|
2021
Q1 | $12.3M | Sell |
|
|||||
|
2020
Q4 | $23.9M | Sell |
|
|||||
|
2020
Q3 | $21.8M | Sell |
|
|||||
|
2020
Q2 | $21.4M | Buy |
|